NEWS
Milestone Achieved: CancerAppy’s First Collaborative Research Paper Unveiled
We are delighted to announce our first collaborative scientific research article. At CancerAppy,...
BIO Spain
We're excited to be part of BioSpain 2023, and despite our packed schedule, we welcome you to...
ATG symbio Spain
Cancerappy participated in the II international congress organized by ATG Symbio Spain that was...
Bio International Convention – Boston 23
Our CEO will be attending the BIO International in Boston from June 5th to 8th. Cancerappy is...
HONG KONG INVEST – European Companies Roadshow
From 15th to 18th of May, our CEO and CMO will be attending various international events in Hong...
MEET2WIN_23
Our CEO Luis Martín Ezama will be attending the #Meet2win23 event 11th and 12th of May, exposing...
Anglonordic 23 – London
April 20th. We are going to attend the 19th Annual Anglonordic Life Science Conference.Meet us to...
CPP21 – InsilicoPROTACs
Cancerappy, together with UCLM, has been awarded the grant from the CCP21 program for the...
AI in drug discovery
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process by...
In the early stages, 97% of drug development fails.
In the early stages, 97% of drug development fails. The discovery and development of a new cancer...
Anglonordic
CancerAppy was present at Anglonordic 2022. An event in which we had the opportunity to contact...
Tel Aviv – SOSA
We are going to stay in Tel Aviv from March 25th through March 28th looking to learn...